Skip to main content

EDITORIAL article

Front. Mol. Biosci., 07 March 2024
Sec. Molecular Biophysics
This article is part of the Research Topic Molecular Level Atomistic and Structural Insights on Biological Macromolecules, Inhibition, and Dynamics Studies View all 13 articles

Editorial: Molecular level atomistic and structural insights on biological macromolecules, inhibition, and dynamics studies

  • 1Computational and Structural Research in Drug Discovery Lab (CSRDD), Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
  • 2Institute of Biostructures and Bioimaging, CNR, Naples, Italy
  • 3Department of Chemical Engineering, Konkuk University, Seoul, Republic of Korea
  • 4Computer Aided Drug Design and Molecular Modelling Lab, Department of Bioinformatics, Science Block, Alagappa University, Karaikudi, Tamil Nadu, India

Introduction

Atoms are the fundamental components of matter, and when they come together, they create molecules. These molecules can then join to create intricate biological structures. Having a deep understanding of how molecules behave at the atomic level has had a significant influence on the pharmaceutical, biotechnology, and chemical sectors (De Vivo et al. 2016). In various scientific disciplines such as chemistry, physics, materials science, and biology, it is essential to thoroughly examine and comprehend the behaviour, structure, and interactions of atoms and molecules (Selvaraj et al. 2023). In particular, researchers are uncovering novel enzyme structures using different experimental and computational techniques. These methods provide a detailed understanding of how enzymes function at the atomic level, their mechanisms, their roles in reactions, and how they can be inhibited (Carvalho et al. 2014). The atom-level illustrations primarily emphasize enzyme kinetics, inhibition, and the analysis of mutations and conformational changes using quantum mechanical and molecular dynamics techniques (Liu et al. 2018). By uncovering the atomic details of the macromolecule, we can gain insights that will aid in the identification of new agonists or antagonists. This, in turn, could lead to the development of potential drug candidates for the treatment of different diseases (Yu and MacKerell 2017). In order to develop a new inhibitor that specifically targets a particular protein, it is essential to thoroughly understand how the active site of the target protein interacts with potential inhibitors. The main goal in designing a new inhibitor is to fully comprehend the molecular interactions between the inhibitor and the target, improve these interactions to ensure a strong binding and specificity, and rigorously test the effectiveness and safety of the inhibitor (Li and Kang 2020).

The following articles in this Research Topic align with the theme of offering insights at the molecular level to identify drug candidates that can bind to the desired drug targets. This is achieved through various computational methods such as modeling calculations, Quantum Mechanics, and molecular dynamics, which demonstrate the wide range of calculations and predictions. Cao et al. conducted a study to investigate how dapansutrile works on NLRP3 and other protein targets in gouty arthritis. They used bioinformatics analysis and a computer simulation framework. The analysis at the molecular and atomic level, using techniques like molecular docking and molecular dynamics simulations, showed that dapansutrile may not only directly inhibit NLRP3 to reduce the inflammatory response and pyroptosis, but also hinder the movement and activation of inflammatory cells by regulating IL1B, IL6, IL17A, IL18, MMP3, CXCL8, and TNF. Mudedla et al. have applied Quantum-based machine learning and AI models to generate force field parameters for drug-like small molecules. They have applied density functional theory (DFT) calculation for 31,770 small molecules that covered the chemical space of drug-like molecules. They also developed the neural network model for assigning atom types, phase angles, and periodicities. They found that an AI-generated force field was influential in the fast and accurate generation of partial charges and other force field parameters for small drug-like molecules. Papathoti et al. have used the molecular docking and simulation methods for investigating the bioactive compounds extracted from the Bacillus sp that target the protein homologs CDC42 of Colletotrichum gloeosporioides causing anthracnose disease in cassava. Five potent compounds from B. megaterium were used to target the protein. The interaction of β-sitosterol and phenylacetic acid with the critical residue of CDC42 demonstrated that ligands may inhibit growth-related functional proteins. They have also constructed the protein-protein interactions network, and from that, they have revealed that targeting the CDC42 protein could impart MAPK (Mitogen-activated protein kinases) signaling pathway. Shaik et al. have come up with a new computational biology dimension to interpret the genotype-protein phenotype relationship between SERPINA1 pathogenic variants with its structural plasticity and functional behaviour with NE ligand molecule contributing to the Alpha-1-antitrypsin deficiency. The molecular docking approach findings have demonstrated that the most missense variants negatively impact the affinity of NE (Neutrophil Elastase) and A1AT binding in a molecular complex, lowering A1AT functionality and contributing to its deficiency. Kamboj et al. have applied Gene expression analysis, molecular docking, and molecular dynamics studies to identify the strong antifungal compounds that show specificity with VelB and THR drug targets to inhibit Curvularia lunata. Luštinec et al. have performed the Ab-initio evaluation for evaluating the acid influence on the chemical stability of hydrophilic diglycolamides. Their results show strong theoretical findings on including an acid influence on the diglycolamides chemical structure, treated in the frame of the density functional theory. Spassov et al. have used the molecular dynamics simulation methods for protonated and non-protonated forms of the inhibitors and suggested that the salt bridge has an unexpected role in stabilizing the NMT protein conformation and that this may be a significant factor in mediating its effects on NMT inhibitors potency. Danazumi et al. conducted microsecond-level MD simulations to comprehend the role of quinolinyl oxamide derivative (QOD) and an indole carboxamide derivative (ICD) as antimalarial lead drugs with dual inhibition of falcipain-2 and falcipain-3. Jang et al. have come up with the AI-assisted de novo design approach to identify a potent and selective inhibitor for the FLT3/FLT-3 (D835Y) mutant. They have optimized the compound PCW-1001 and generated the 10,416 analogues using the LSTM approach. Achudhan et al. identified the novel nitrilases compounds from a coal metagenome using the in silico mining methods. The binding scores produced by the novel nitrilase were approximately similar to those of the other prokaryotic nitrilase crystal structures, with a deviation of ±0.5. Kirubhanand et al. analyzed the bioactive nature of lochnericine against Non-Small Cell Lung Cancer (NSCLC) using various computational approaches such as quantum chemical calculations, molecular docking, and molecular dynamic simulation. Also, they confirmed the molecule’s potential bioactivity based on the band gap energy value associated with bioactive compounds through Frontier Molecular Orbital (FMO). Shaik et al. provide comprehensive computational and structural insights into the genotype-protein phenotype correlation of the PCSK9 (Proprotein convertase subtilisin/kexin type 9) pathogenic variant with a PCSK9 inhibitor monoclonal antibody.

In general, the authors of these articles have used Artificial Intelligence and molecular modeling approaches to bring insightful information on atomistic mechanisms and explore functions of the biological macromolecule using atom-level calculations (Huggins et al. 2012; Selvaraj et al. 2022). Some studies have performed extensive molecular dynamics simulations like microsecond level molecular dynamics simulations and accurate Quantum Mechanical Calculations for understanding the atomic role in molecular mechanisms (Sakkiah et al. 2021). The conclusions of the major articles are based on theoretical approaches from the software and publicly available information, with very little confirmation in laboratory conditions. In the future, the added advantage of experimental findings supporting these theoretical findings is required to confirm these findings.

Author contributions

CS: Funding acquisition, Project administration, Supervision, Validation, Writing–original draft, Writing–review and editing. EP: Data curation, Formal Analysis, Funding acquisition, Resources, Visualization, Writing–review and editing. J-KL: Formal Analysis, Funding acquisition, Investigation, Resources, Validation, Visualization, Writing–review and editing. SS: Data curation, Formal Analysis, Funding acquisition, Methodology, Resources, Visualization, Writing–review and editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and funded by the Ministry of Science, ICT, and Future Planning (NRF-2022M3A9I3082366).

Acknowledgments

The author CS thankfully acknowledges the Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai for providing the infrastructure facility.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Carvalho, A. T., Barrozo, A., Doron, D., Kilshtain, A. V., Major, D. T., and Kamerlin, S. C. (2014). Challenges in computational studies of enzyme structure, function and dynamics. J. Mol. Graph Model 54, 62–79. doi:10.1016/j.jmgm.2014.09.003

PubMed Abstract | CrossRef Full Text | Google Scholar

De Vivo, M., Masetti, M., Bottegoni, G., and Cavalli, A. (2016). Role of molecular dynamics and related methods in drug discovery. J. Med. Chem. 59 (9), 4035–4061. doi:10.1021/acs.jmedchem.5b01684

PubMed Abstract | CrossRef Full Text | Google Scholar

Huggins, D. J., Sherman, W., and Tidor, B. (2012). Rational approaches to improving selectivity in drug design. J. Med. Chem. 55 (4), 1424–1444. doi:10.1021/jm2010332

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, Q., and Kang, C. (2020). Mechanisms of action for small molecules revealed by structural biology in drug discovery. Int. J. Mol. Sci. 21 (15), 5262. doi:10.3390/ijms21155262

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, X., Shi, D., Zhou, S., Liu, H., Liu, H., and Yao, X. (2018). Molecular dynamics simulations and novel drug discovery. Expert Opin. Drug Discov. 13 (1), 23–37. doi:10.1080/17460441.2018.1403419

PubMed Abstract | CrossRef Full Text | Google Scholar

Sakkiah, S., Selvaraj, C., Guo, W., Liu, J., Ge, W., Patterson, T. A., et al. (2021). Elucidation of agonist and antagonist dynamic binding patterns in ER-α by integration of molecular docking, molecular dynamics simulations and quantum mechanical calculations. Int. J. Mol. Sci. 22 (17), 9371. doi:10.3390/ijms22179371

PubMed Abstract | CrossRef Full Text | Google Scholar

Selvaraj, C., Chandra, I., and Singh, S. K. (2022). Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries. Mol. Divers 26 (3), 1893–1913. doi:10.1007/s11030-021-10326-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Selvaraj, C., Panwar, U., Ramalingam, K. R., Vijayakumar, R., and Singh, S. K. (2023). Exploring the macromolecules for secretory pathway in cancer disease. Adv. Protein Chem. Struct. Biol. 133, 55–83. doi:10.1016/bs.apcsb.2022.10.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Yu, W., and MacKerell, A. D. (2017). Computer-aided drug design methods. Methods Mol. Biol. 1520, 85–106. doi:10.1007/978-1-4939-6634-9_5

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: molecular modeling, molecular dynamics, quantum mechanics, atomic insights, drug targets

Citation: Selvaraj C, Pedone E, Lee J-K and Singh SK (2024) Editorial: Molecular level atomistic and structural insights on biological macromolecules, inhibition, and dynamics studies. Front. Mol. Biosci. 11:1362215. doi: 10.3389/fmolb.2024.1362215

Received: 27 December 2023; Accepted: 19 February 2024;
Published: 07 March 2024.

Edited and reviewed by:

Ioan Andricioaei, University of California, Irvine, United States

Copyright © 2024 Selvaraj, Pedone, Lee and Singh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Chandrabose Selvaraj, selva@csrdd.org, boselab2w@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.